Amgen

YTD

ALL

Trade Amgen 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About AMGN

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K.

CEO

Robert A. Bradway

CEORobert A. Bradway

Employees

31,500

Employees31,500

Headquarters

Thousand Oaks, California

HeadquartersThousand Oaks, California

Founded

1980

Founded1980

Employees

31,500

Employees31,500

AMGN Key Statistics

Market cap

198.30B

Market cap198.30B

Price-Earnings ratio

25.84

Price-Earnings ratio25.84

Dividend yield

2.64%

Dividend yield2.64%

Average volume

2.09M

Average volume2.09M

High today

$370.99

High today$370.99

Low today

$366.75

Low today$366.75

Open price

$369.15

Open price$369.15

Volume

261.66K

Volume261.66K

52 Week high

$391.29

52 Week high$391.29

52 Week low

$269.77

52 Week low$269.77

Stock Snapshot

As of today, Amgen(AMGN) shares are valued at $367.43. The company's market cap stands at 198.3B, with a P/E ratio of 25.84 and a dividend yield of 2.64%.

During the trading session on 2026-07-22, Amgen(AMGN) shares reached a daily high of $370.99 and a low of $366.75. At a current price of $367.43, the stock is +0.2% higher than the low and still -1.0% under the high.

Trading activity shows a volume of 261.66K, compared to an average daily volume of 2.09M.

The stock's 52-week range extends from a low of $269.77 to a high of $391.29.

AMGN News

TipRanks 2h

Amgen reaches $74M lawsuit settlement over tax bill, Reuters reports

Amgen (AMGN) has reached a $74M settlement of a lawsuit accusing the company of waiting too long to disclose that it might owe the U.S. Internal Revenue Service...

Benzinga 19h

$100 Invested In Amgen 15 Years Ago Would Be Worth This Much Today - Benzinga

...

Simply Wall St 4d

Amgen Earnings Buzz Builds, Is The Stock Already Overvalued?

Advertisement Why Amgen’s Earnings Setup Is Drawing Attention Now Amgen (AMGN) is back in focus after a recent run of earnings surprises, with the stock drawi...

Analyst ratings

49%

of 35 ratings

Buy

40%

Hold

48.6%

Sell

11.4%

More AMGN News

TipRanks 5d

Amgen Halts Bemarituzumab Gastric Cancer Trial, Shifting Oncology Expectations

Amgen Inc (AMGN) announced an update on their ongoing clinical study. TipRanks has entered a new arena in the investing world, powering the index of an ETF bas...

People also own

Based on the portfolios of people who own AMGN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.